Harshini Neelakantan

Harshini  Neelakantan

Company: Ridgeline Therapeutics

Job title: Executive Director, Research & Development

Seminars:

Correcting Dysregulated Fat Metabolism: Unraveling a Novel Approach to Reverse Obesity, NASH & Type 2 Diabetes 12:00 pm

Leveraging an oral small molecule therapeutic to sustainably modulate adipose tissue metabolism Targeting the root cause: preventing or reversing fatty liver disease and the progression to NASH Obesity, NASH, and T2D: interrogating animal studies and translation to the clinicRead more

day: Day 1 Stream 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.